The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...
Supira Medical has raised $120 million to complete the clinical development of its temporary heart pump, designed for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback